Brain Cancer


First In Class Immunostimulating Anticancer Agent able to Directly Inhibit Tumor Signaling and Kill Tumor Cells, is in Clinical Trial for Glioblastoma and Melanoma Metastatic to the Brain (09-13-2018)

Small molecule lead drug candidate blocks a critical target for tumors and crosses the blood brain barrier; begins first brain cancer patient dosing in clinical trial at MD Anderson Cancer Center HOUSTON, TX – September 13, 2018 – In the ongoing... Continue Reading

Engineering the Common Cold Virus Appears to be Promising Treatment Approach for Some Brain Tumors (07-6-2018)

A “smart bomb” oncolytic adenovirus appears to induce dramatic responses with long-term survival in recurrent high-grade gliomas, according to the early results of a study published in The Journal of Clinical Oncology. Glioblastoma is the... Continue Reading

Interim Survival Data from Phase 3 Trial of DCVax®-L for Glioblastoma Reported (05-30-2018)

Northwest Biotherapeutics, developer of DCVax® personalized immune therapies for solid tumor cancers, announced today the publication of interim blinded survival data from its Phase 3 clinical trial of DCVax®-L for newly diagnosed Glioblastoma brain... Continue Reading

Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit (05-29-2018)

The research team behind an emerging immunotherapy for cancer will present interim findings from an ongoing clinical study in patients with brain cancer at a major research meeting next month. Collaborators from organizations including Roswell Park Comprehensive... Continue Reading

Temodar® plus Radiation Improves Survival for Brain Cancer (03-31-2009)

Radiation therapy plus chemotherapy with Temodar® (temozolomide) improves survival in patients with glioblastoma; almost 10% of patients treated with the combination therapy were alive after five years, compared with 2% of patients treated with radiation... Continue Reading

Treatment Guidelines for Patients with Newly Diagnosed Glioblastoma Multiforme (10-1-2008)

Treatment Guidelines for Patients with Newly Diagnosed Glioblastoma Multiforme For the first time ever, the American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors has issued treatment guidelines... Continue Reading